Launching a private label acne spot treatment is about more than formulation — packaging and labeling decisions can make or break your market entry. A balm product that meets efficacy expectations but fails regulatory labeling requirements may be rejected at customs, pulled from shelves, or trigger costly reformulation cycles.
This guide walks you through the three major regulatory frameworks — FDA (US), EU Cosmetic Regulation, and general international standards — as they apply to acne spot treatment balms containing active ingredients such as calamine and sulfur. You will learn which label elements are mandatory, how packaging material choices affect stability and compliance, and what sustainable options are available for brands targeting multiple markets.
Acne spot treatment products occupy a unique regulatory space. Because they contain active ingredients like calamine and sulfur — substances with recognized antibacterial and skin-soothing properties — regulators in multiple jurisdictions scrutinize both the product formulation and its packaging claims. A balm labeled as "overnight pimple treatment" in one market may require different wording, warning statements, or even a different product classification in another.
Non-compliance carries tangible risks. The FDA may issue warning letters or detention notices for cosmetic products that make drug-like claims on their labels. In the EU, the Responsible Person under Regulation (EC) No 1223/2009 can face enforcement actions if a product's labeling does not meet the prescribed format, including ingredient listing using INCI nomenclature and proper notification via the Cosmetic Product Notification Portal (CPNP).
For private label brands sourcing from OEM manufacturers, the stakes are particularly high. A manufacturer such as Lanthome, which operates a GMP-certified facility and offers customizable formulation and packaging services for products like its OEM 3H Fast Acting Overnight Drying Balms, can support compliance by supplying full ingredient documentation and regulatory dossiers. However, the brand owner remains legally responsible for final label accuracy in the destination market.
Under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and the Fair Packaging and Labeling Act (FPLA), cosmetic products sold in the United States must follow a defined labeling framework. The FDA provides detailed guidance in its Cosmetic Labeling Guide, which outlines every mandatory and voluntary label element.
The PDP — the part of the package most likely to be displayed at retail — must include:
The information panel, typically on the side or back of the package, must include:
The most common compliance pitfall for acne spot treatments is the drug-vs-cosmetic boundary. The FDA considers a product a drug if it is "intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease" or "intended to affect the structure or any function of the body." Acne treatment claims such as "treats acne," "eliminates pimples," or "clinically proven to heal blemishes" may push a product into the OTC drug monograph category, requiring a drug establishment registration and NDC code. The American Academy of Dermatology (AAD) notes that cosmetic acne-care products should use language such as "helps reduce the appearance of blemishes" or "supports clearer-looking skin" to remain firmly in the cosmetic category.
The EU's regulatory framework, detailed by the European Commission Cosmetics Regulation, imposes a distinct set of labeling requirements that are generally more prescriptive than the FDA's approach. Brands exporting acne balms to EU member states must comply with the following mandatory elements.
Every cosmetic product placed on the EU market must display, in indelible, easily legible, and visible lettering:
Before placing a product on the EU market, the Responsible Person must notify the European Commission via the Cosmetic Product Notification Portal (CPNP). This notification includes product category, frame formulation, and label artwork. Manufacturing partners with GMP-certified facilities can supply the necessary formulation data, but the notification obligation falls on the Responsible Person.
The physical packaging of an acne spot treatment balm matters for consumer experience, formulation stability, and regulatory compliance. Three primary formats dominate the market: squeeze tubes, jars, and airless pump systems. Each carries distinct advantages and regulatory considerations for a calamine sulfur formulation, such as those used in the Face Care collection at Lanthome.
Squeeze tubes are a common choice for balm products because they minimize air exposure and reduce the risk of microbial contamination. Tubes can be manufactured from aluminum, laminated materials, or plastic (PE, PP). For acne spot treatments, laminated tubes with a narrow orifice allow precise application directly onto blemishes, reducing product waste.
Jars offer a premium look and easy access but present stability challenges. Each time a consumer opens a jar, the product contacts air and fingers, introducing oxygen and potential microbial contamination. For this reason, jar-packaged acne balms should include adequate preservative systems validated through challenge testing per ISO 11930.
Airless packaging is increasingly popular for high-value treatment products. The vacuum mechanism prevents air ingress, protecting oxidation-sensitive ingredients like vitamin C and vitamin E — both of which are present in the Lanthome acne balm. Airless systems also support preservative-free or low-preservative formulations, which appeal to the clean beauty segment.
Regardless of format, packaging materials must undergo compatibility and migration testing with the actual formulation. Sulfur and calamine can react with certain metals and plastics, potentially causing discoloration, odor changes, or container degradation. The ISO 22715:2006 standard addresses cosmetic packaging and labeling, and manufacturers should request compatibility certificates from packaging suppliers before committing to a material.
While cosmetic balms are generally not required to use child-resistant packaging, brands that market acne spot treatments in certain formats or distribution channels may face specific requirements or consumer expectations.
The Poison Prevention Packaging Act (PPPA) does not typically apply to cosmetic products unless they contain substances that are hazardous to children. However, products packaged in formats that could be mistaken for food or candy may attract regulatory attention. Balms in small, colorful containers with fruit-like fragrances should include clear "keep out of reach of children" labeling.
Tamper-evident packaging — such as induction seals, tear bands, or shrink sleeves — is increasingly expected by both consumers and retail buyers. For private label brands, it serves dual purposes: regulatory compliance for markets that require it and consumer confidence.
Sustainability is no longer optional in the cosmetics industry. According to market data, over 70% of global consumers consider eco-friendly packaging a purchasing factor, and regulators are responding with mandates. The EU Packaging and Packaging Waste Regulation (PPWR), adopted in 2024, sets binding targets for packaging reduction, recyclability, and recycled content.
Tubes and jars incorporating PCR plastic are the most accessible sustainability upgrade for acne balm brands. PCR content of 30–50% is commercially available, though brands should verify that PCR materials do not compromise barrier properties or leach compounds into the product over its 3-year shelf life.
Monomaterial tubes — typically all-PE or all-PP — are designed for single-stream recycling. This contrasts with conventional laminated tubes, which combine aluminum, paper, and multiple plastic layers that cannot be easily separated.
For premium acne treatment lines, refillable jar or compact systems create a differentiated value proposition. The initial purchase includes a durable outer case, and consumers replace only the inner balm cartridge. This model reduces total packaging weight per unit sold and supports customer retention.
A packaging system that performs well on the shelf may fail during international shipping. Acne spot treatment balms face specific transit risks: temperature extremes, pressure changes, vibration, and rough handling.
Balm formulations are sensitive to heat. A calamine sulfur balm may soften or melt at temperatures above 40°C (104°F), which is common in shipping containers during summer months. Packaging must account for this: tubes should include adequate headspace and sealed closures that prevent leakage even if the product liquifies temporarily.
ISTA (International Safe Transit Association) testing protocols simulate real-world shipping conditions. A packaged acne balm should survive a 1-meter drop test without container rupture or closure failure. Stability testing per ICH Q1A(R2) guidelines — though designed for pharmaceuticals — provides a rigorous framework for cosmetic brands.
Lanthome's OEM team can coordinate with brand owners to ensure outer packaging meets multi-market requirements, drawing on the About Us manufacturing capabilities that serve 150+ countries.
Do I need FDA approval for private label acne balm labels?
No. The FDA does not pre-approve cosmetic product labels. However, the FDA can take enforcement action against misbranded cosmetics — those with false or misleading labeling — at any time after the product enters the market.
What is the difference between FDA and EU ingredient labeling rules?
The EU requires all nanomaterials to be labeled with "(nano)" after the INCI name. The FDA does not have a specific nanomaterial labeling requirement for cosmetics. The EU also mandates the "period-after-opening" symbol on products with a shelf life exceeding 30 months, while the FDA does not require this.
Can I use the same label for US and EU markets?
Rarely. While the ingredient declaration can be harmonized using INCI nomenclature, the US and EU differ in language requirements, net quantity formatting, responsible person identification, warning statements, and the PAO symbol. A single global label design typically requires a multi-language booklet label or separate regional SKUs.
What packaging is best for a calamine and sulfur acne balm?
Airless pump systems or narrow-orifice squeeze tubes are ideal because they minimize air exposure, reduce contamination risk, and allow precise spot application. The packaging material must be chemically compatible with sulfur-containing formulations.
How do sustainable packaging requirements affect cosmetic balms?
Brands targeting the EU market should prioritize monomaterial or PCR-content packaging to meet upcoming PPWR requirements. Brands should also ensure that any environmental claims on packaging are substantiated with supporting evidence per the EU Green Claims Directive.
About the Author
This article was prepared by the Lanthome skincare manufacturing team, with experience in private label formulation, packaging development, quality control, and international OEM/ODM projects.
